By Katie Gerbasich

Kathryn Kisska-Schulze, J.D., LL.M., a Robert H. Brooks Sports Science Institute Faculty Fellow and the Elliott Davis Associate Professor in the School of Accountancy in The Wilbur O. and Ann Powers College of Business, recently published work on athlete name, image and likeness (NIL) rights that was relied upon by the Tennessee legislature in 2025. Her article, An Evolving Landscape: Name, Image and Likeness Rights in High School Athletes, co-authored by Adam Epstein from Central Michigan University and Nathaniel Grow from Indiana University, was cited as a research reference and practice aid in drafting Tenn. Code Ann. § 47-25-1103, which addresses NIL rights.

The article examines the evolving NIL landscape for high school student-athletes, identifying potential financial risks and proposing a framework to better protect minor student-athletes entering endorsement agreements.

“This honor showcases the impact our research can have on major state legislative interests,” Kissaka-Schulze said.

In spring 2024, Kisska-Schulze launched the School of Accountancy’s first undergraduate sports law course. She also teaches a graduate sports law course for the College of Business’ Master of Science in Sports Business and Analytics program.

Kisska-Schulze has served as chair of the Sports and Entertainment Law Section of the Academy of Legal Studies in Business, represents the College of Business on Clemson University’s Faculty Athletic Council, and was recently named a Brooks Sports Science Institute Fellow.

Individuals who suffer from chronic pain have increasingly come to rely on kratom, a Southeast Asian plant whose principal psychoactive alkaloids, mitragynine and 7-hydroxymitragynine (7-OH), may soon become Schedule I Controlled Substances in the United States. The two compounds bind to, and partially activate, opioid receptors in the brain.

“People in Southeast Asia have long relied on teas brewed from kratom leaves not only to manage pain but to ease the symptoms of opiate withdrawal,” said Bryan E. Denham, Ph.D., Campbell Professor of Sports Communication in the Department of Communication at Clemson. “Although kratom is not entirely safe, it appears to be less hazardous than concentrated, synthetic versions of 7-OH, manufactured by unscrupulous firms. Synthetics are sold at gas stations and vape stores and are packaged to attract the attention of high-school and college-aged individuals.”

Denham’s study appears in the Journal of Substance Use and addresses the extent to which kratom use correlates with health concerns and signs of dependency on other substances. One finding showed that individuals struggling to quit prescription pain relievers were more than four times as likely as others to have used kratom, a substance the Drug Enforcement Administration (DEA) considers “drug of concern.” In July 2025, the Food and Drug Administration (FDA) advised the DEA to add mitragynine and 7-OH to the list of Controlled Substances, and the DEA is currently considering that recommendation.

“It will be interesting to see what the DEA chooses to do in the coming months,” Denham said. “It announced plans in 2016 to ban mitragynine and 7-OH, but it received significant pushback from kratom users. This time, the FDA has made it a point to state plainly that its recommendation does not include the kratom plant itself. It is primarily interested in the two alkaloids and especially the hazardous synthetic products. A trade group, the American Kratom Association, has endorsed the recommended actions on mitragynine and 7-OH.”

Denham studies the media, health, and policy aspects of substance use in sport and society. He said that in sport, athletes have used kratom to increase energy and to recuperate from intense exercise. Some athletes believe it enhances their focus during competition, and some experiment with it for pain relief. Technically, kratom is not a banned substance, but the United States Anti-Doping Agency advises athletes to avoid using it given potential side effects. Athletes and non-athletes alike should appreciate that kratom is a drug, not a dietary supplement, and they should be aware of manipulative labels on synthetic substances.

In addition to his study in the Journal of Substance Use, Denham has examined the agenda-building function of mass media on kratom policy, exploring how coverage in major national news outlets and regional news organizations has impacted regulatory action. Denham said the Tampa Bay Times, in particular, has examined kratom use in depth, and its reporting has impacted coverage elsewhere in addition to policy conversations at the state and national levels.

By Katie Gerbasich

Division 1 student-athletes already battle the complexities of balancing classes with practices and a social life. When medical conditions emerge, the situation is elevated to a new level. Using funding from the Robert H. Brooks Sports Science Institute (RHBSSI), Department of Communication faculty and RHBSSI fellows, Brandon Boatwright, Ph.D., and Rikishi Simith-Rey, Ph.D., are conducting an exploratory study, hoping to illuminate student-athletes’ challenges as they compete at a high level while managing chronic illnesses and autoimmune diseases. 

His own journey with an autoimmune disease inspired Boatwright. After a conversation with former Division Ⅰ athlete, Smith-Rey, the idea for the study was born. The two are now working with students Marissa Bennett and Ava Quallen, from the Departments of Communication and Health Science, respectively, to find ways to assist these athletes. 

“Life as a student-athlete is complicated and complex already, but to feel like you’re fighting against your own body in the context of being a college student and trying to navigate your schedule builds the stresses of all that,” Boatwright said. 

A key point in the research has been identifying what resources are available for these individuals. There is a fluctuation in availability among Division Ⅰ programs, and an even greater disparity when comparing Division Ⅰ  to Division Ⅱ.  

“When we think about resources here at Clemson, student-athletes have some of the best stuff, but not everyone goes to Clemson,” Smith-Rey said. “Not everyone, even if you are D1, has the same resources, so how can we identify what resources student athletes need? What ways can we assist them in communicating their needs to other stakeholders in their lives?”

The study is currently in the data collection process. The team has spoken with different student-athletes across various sports with Type 1 Diabetes, rheumatoid arthritis, and Crohn’s disease, among other illnesses. 

“The folks we have spoken with have been incredible people and athletes competing at such a super high level,” Boatwright said. “They are just incredible people for having to deal with the things that they have dealt with and still preserving.”

Smith-Rey commends these interviews for being a space where these student-athletes feel seen. Often, chronic illnesses or autoimmune diseases have an element of invisibility that makes communication a challenge. 

After speaking with the team, these athletes feel like someone understands their unique story. Boatwright shared a narrative about an athlete with Rheumatoid Arthritis. 

“They would just have to wake up and tell players, teammates, coaches or someone that it’s not gonna happen because I can’t get out of bed,” Boatwright said. “‘I physically just can not sit up enough to get out of bed. It’s just one of those days.’” 

Athletic programs and teams can become better advocates by better understanding the challenges these athletes face due to their medical conditions. 

“We can be that support button right now,”  Smith-Rey said. “Someone is speaking up for you and looking for ways to assist you in this.” 

If you are or were an athlete who competed at the Division Ⅰ  to Division Ⅱ level, are no more than five years removed from your sport, and were diagnosed with a chronic illness or autoimmune disease before competing in college, click here to set up an interview.